Breast cancer vax promises early protection

Cleveland Clinic star investigator Dr. Vincent Tuohy is scouting for $16 million to help fund human trials of an experimental breast cancer vaccine designed to stop cancer from developing as a woman ages. With Dendreon's Provenge putting a spotlight on new therapeutic cancer vaccines, Tuohy wants to create a vaccine that works the way childhood vaccines do; protecting women from a lethal and all-too-common disease. Report

Suggested Articles

Denali is partnering with Biogen on its Parkinson's disease program, netting a $560 million upfront fee and a $465 million investment.

In the first half of 2020, the regenerative medicine sector raised $10.7 billion, more than the total it raised in 2019.

The trial linked RG6346 to reductions in hepatitis B surface antigen that suggest the RNAi therapy can hold its own against drugs from J&J and Vir.